Navigation Links
BioMarin's Chief Executive Jean-Jacques Bienaime to Receive Most Admired CEO Award From San Francisco Business Times
Date:10/9/2009

rcialization.

"It is a great honor to be recognized among some of the Bay Area's most esteemed corporate leaders," said Mr. Bienaime. "I would especially like to extend my gratitude to BioMarin employees who have persevered through great challenges and change, and to also remember the patients we serve."

Mr. Bienaime has worked in the Bay Area biopharmaceutical industry for more than 25 years, with a significant track record of executive-level leadership positions throughout that time. Recently, Mr. Bienaime was named among the Top 5 Best CEOs in the Healthcare Sector by Institutional Investor Magazine. Under his leadership BioMarin has also received multiple industry awards including BayBio's DiNA Pantheon Award for Outstanding Company, and the NORD (National Organization for Rare Disorders) Partners In Progress Corporate Award to name a few.

About Jean-Jacques Bienaime

Mr. Bienaime joined BioMarin in May 2005 as chief executive officer and member of the board of directors, bringing with him over 25 years of experience in the biotechnology and pharmaceutical industries. Under his leadership, the market capitalization of BioMarin went from around $450 million in May 2005 to over $3.5 billion in May 2008. BioMarin 2009 revenues are expected to be more than $300 million. BioMarin is a fully integrated biopharmaceutical company with nearly 700 employees. From November 2002 to April 2005, Mr. Bienaime served as chairman, chief executive officer, and president of Genencor, a biotechnology company focused on industrial bioproducts and targeted cancer biotherapeutics. Under his leadership, Genencor's revenues increased substantially to over $400 million and shareholder value increased dramatically, culminating in the sale of the company to Danisco in the spring of 2005 for an enterprise value of over $1.2 billion. From 1998 to late 2002, Mr. Bienaime served as chairman, chief executive officer and president of Sa
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
2. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. China Technology Announces New Chief Financial Officer
8. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
9. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
10. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
11. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...nnel need to be able to find explosive materials a...aid such searches, the National Institute of Stand...Department of Homeland Security, has developed a n...e Material (SRM) 2905, Trace Particulate Explosive...ods, the SRM will be helpful in calibrating, testi...
(Date:11/18/2009)..., Calif., Nov. 18 Sangam...ay that data from the University of Pennsylvania i...amo,s zinc finger nuclease (ZFN) based product, SB...urely disclosed on the internet. ,, Data were p...Pennsylvania School of Medicine from a single subj...
(Date:11/18/2009)...STEAD, West Sussex, U.K. and CLEVELAND, Nov. 18 /P...Biosciences business and premier provider of diagn...obiology labs, has expanded its East Grinstead, U....ility to meet increasing global demand for its Sen...identification testing. The expanded facility has ...
(Date:11/18/2009)... Promega Corporation and SwitchGear Genomics ...tein interactions. , Madi...Corporation and SwitchGear Genomics announce a nov...ons. Results of a study using the HaloCHIP™ ...rate the ability to correlate DNA binding events t...
Breaking Biology Technology:New NIST trace explosives standard slated for homeland security duty 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2
..., March 2 American Pacific Corporation (Nasdaq: ...ed subsidiary AMPAC Fine Chemicals LLC (AFC) recei...Award from the Department of Toxic Substances Cont... Council of California (CICC). The award recognize... AFC,s STRIDE (Sustainability Through Renewable In...
..., Pa., March 2 Morphotek(R), Inc., a subsidiary o...ced that it has commenced a,multi-centered Phase I...sothelioma. The study will evaluate MORAb-009, plu...m, as a first-line treatment for patients with,mes...y is to assess the efficacy of MORAb-009,as combin...
..., March 2 /PRNewswire-FirstCall/ - Angiotech Pharm... announced it has obtained a new Senior Secured Te... Foothill, LLC is the sole arranger, administrativ...lving Credit Facility. , The financing includes a ...10 million, and a secured revolving credit facilit...
Other Biology Technology:AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years 2AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years 3Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 2Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 2Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 4
(Date:11/19/2009)... Leaf-cutter ants, which cultivate fungus for foo...ew one to add to the list: the ant farmers, like t... bacteria to make their gardens grow. The finding,...nce , documents a previously unknown symbiosis bet...ow leaf-cutter ants have come to dominate the Amer...
(Date:11/19/2009)...s an important crop in many countries of the world...feed, and industrial materials. It also is conside...cation, molecular evolution, and genome architectu...special collection used the first description of t...iguing questions in genetics and plant biology. Th...
(Date:11/19/2009)... Spring Harbor, NY A four-year, multi-institution...atory (CSHL) scientists culminated today in public...l Science revealing in unprecedented detail the ..., as it is commonly called by North American consu...and the most valuable agricultural crop grown in t...
Breaking Biology News(10 mins):Like humans, ants use bacteria to make their gardens grow 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 1Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 3HOYA ConBio Announces Educational Alliance with LVI Global Australia 55683 1HOYA ConBio Announces Educational Alliance with LVI Global Australia 55683 2Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 1Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 2
...may have found why women have an edge in keeping a... eat and excrete - at least before reaching menopa...r problems with salt-sensitive hypertension and hy...re essentially the same as men, says Dr. David Pol...enter at the Medical College of Georgia. , The re...
...9) Virginia Commonwealth University researchers h...in regulating mitochondria, the energy-producing m...d to the development of new treatments for heart d...to master the abnormal metabolism of cancer. , In...xpress, researchers reported that Stat3, a protein...
.... It occurs when changes take place in the genes t...h, cell signalling and blood vessel formation eit...ch as smoking or radiation or due to inherited ch...d environmental factors means that cancer is an ex...endometrial carcinoma, is no exception. , Cancer ...
Other Biology News:Researchers may have found why women have an edge on salt-sensitive hypertension 2New research findings may enable earlier diagnosis of uterine cancer 2
...teinChip arrays have been developed for affinity c...ety of ProteinChip chemical surfaces allow differe...e biochemical properties. Each chip has eight diff...on, and the chips are color-coded with a unique hy...
SmartSpec Printer Paper, 5 pack from Bio-Rad
...teinChip arrays have been developed for affinity c...ety of ProteinChip chemical surfaces allow differe...e biochemical properties. Each chip has eight diff...on, and the chips are color-coded with a unique hy...
...ssay with SR-101 Labeled Substrates (red fluoresce...re serine protease activation • No lysing, fi...Kits utilize cell-permeable, fluorescently labeled...e chymotrypsin-like activity in whole living cells...
Biology Products: